CLVS

Clovis Oncology, Inc. Competitors

$56.27
*  
0.49
0.88%
Get CLVS Alerts
*Delayed - data as of Dec. 18, 2014 12:33 ET  -  Find a broker to begin trading CLVS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    CLVS Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Competitor Industry: Major Pharmaceuticals

Clovis Oncology, Inc.
CompanyName
Symbol: Market
LastSale NetChange ▼ Volume Today's High / Low 52 Weeks High / Low P / E Ratio Market Cap
Ovascience Inc.
OVAS: NASDAQ-GM
$ 46.10 11.14 ▲ 1,250,266 $ 49.94
$ 41.96
$ 36.54
$ 5.509
NE 1,118,847,000
Regeneron Pharmaceuticals, Inc.
REGN: NASDAQ-GS
$ 421.56 10.57 ▲ 341,229 $ 422.99
$ 412.3956
$ 437.6384
$ 257.69
142.42 41,771,115,720
Intercept Pharmaceuticals, Inc.
ICPT: NASDAQ-GS
$ 148.9965 8.29 ▲ 430,198 $ 150.50
$ 143.75
$ 497
$ 54.02
NE 3,161,407,737
Taro Pharmaceutical Industries Ltd.
TARO: NYSE
$ 145.64 7.71 ▲ 36,727 $ 145.74
$ 140.23
$ 168.99
$ 93
15.97 6,238,052,480
Alexion Pharmaceuticals, Inc.
ALXN: NASDAQ-GS
$ 187.78 5.70 ▲ 654,378 $ 188.75
$ 184
$ 203.30
$ 122.69
78.24 37,145,700,700
Puma Biotechnology Inc
PBYI: NYSE
$ 206.42 5.08 ▲ 122,129 $ 208.24
$ 200.0035
$ 279.37
$ 53.63
NE 6,223,150,160
Tetraphase Pharmaceuticals, Inc.
TTPH: NASDAQ-GS
$ 38.16 4.97 ▲ 958,168 $ 39.50
$ 37.45
$ 33.22
$ 8.01
NE 1,166,169,600
Perrigo Company
PRGO: NYSE
$ 163.68 4.53 ▲ 685,505 $ 164.10
$ 158.39
$ 168.39
$ 125.37
137.55 21,925,918,080
Allergan, Inc.
AGN: NYSE
$ 212.22 4.19 ▲ 1,280,270 $ 213.61
$ 209.545
$ 214.66
$ 98.78
49.47 63,220,125,780
Shire plc
SHPG: NASDAQ-GS
$ 219.13 3.88 ▲ 506,518 $ 221.20
$ 217.50
$ 264.98
$ 136.29
33.25 131,167,273,660
MacroGenics, Inc.
MGNX: NASDAQ-GS
$ 33.04 3.79 ▲ 968,990 $ 33.16
$ 28.23
$ 41
$ 17.31
NE 916,496,560
Actavis, Inc.
ACT: NYSE
$ 264.67 3.77 ▲ 1,304,546 $ 268.37
$ 263.11
$ 272.75
$ 158.57
NE 70,153,694,870
Vertex Pharmaceuticals Incorporated
VRTX: NASDAQ-GS
$ 115.48 3.63 ▲ 815,204 $ 115.86
$ 111.66
$ 122.26
$ 59.79
NE 27,493,709,360
Receptos, Inc.
RCPT: NASDAQ-GS
$ 126.76 3.17 ▲ 255,734 $ 128.35
$ 125.05
$ 135.37
$ 24.5345
NE 3,457,886,040
BioMarin Pharmaceutical Inc.
BMRN: NASDAQ-GS
$ 90.075 2.87 ▲ 674,717 $ 91.32
$ 88.12
$ 96.355
$ 55.04
NE 13,251,563,775
Insys Therapeutics, Inc.
INSY: NASDAQ-GM
$ 45.97 2.84 ▲ 344,861 $ 46.30
$ 43.05
$ 57.9133
$ 20.52
31.63 1,586,424,700
Valeant Pharmaceuticals International, Inc.
VRX: NYSE
$ 142.70 2.70 ▲ 1,225,165 $ 143.08
$ 139.53
$ 153.10
$ 106
97.07 47,900,537,100
Alnylam Pharmaceuticals, Inc.
ALNY: NASDAQ-GS
$ 99.09 2.64 ▲ 291,507 $ 99.52
$ 96.83
$ 112.57
$ 47.03
NE 7,566,016,950
NewLink Genetics Corporation
NLNK: NASDAQ-GM
$ 37.01 2.48 ▲ 249,232 $ 37.11
$ 34.75
$ 53.48
$ 17.3201
NE 1,032,912,090
Agios Pharmaceuticals, Inc.
AGIO: NASDAQ-GS
$ 118.49 2.41 ▲ 480,939 $ 119.33
$ 115.0407
$ 124.3899
$ 21.01
NE 4,082,928,420
PTC Therapeutics, Inc.
PTCT: NASDAQ-GS
$ 53.24 2.36 ▲ 291,437 $ 54.6999
$ 52.60
$ 56.99
$ 14.51
NE 1,762,403,720
Chimerix, Inc.
CMRX: NASDAQ-GM
$ 38.90 2.31 ▲ 190,067 $ 38.98
$ 36.99
$ 39.06
$ 13.94
NE 1,581,557,300
Paratek Pharmaceuticals, Inc.
PRTK: NASDAQ-GM
$ 36.09 2.28 ▲ 46,724 $ 36.64
$ 33.85
$ 34.92
$ 1.55
NE 520,345,620
Jazz Pharmaceuticals plc
JAZZ: NASDAQ-GS
$ 168.66 2.26 ▲ 333,159 $ 170.55
$ 167.09
$ 183.84
$ 110.675
392.23 10,156,873,860
Celgene Corporation
CELG: NASDAQ-GS
$ 114.99 2.17 ▲ 2,620,769 $ 116.20
$ 114.56
$ 119.84
$ 66.85
60.2 91,935,654,900